AzTrials
AzTrials

Firearm InjuryNCT06263647

Launching the Houston Hospital-Based Violence Intervention Program (Houston-HVIP): Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence

A study testing Houston-HVIP treatment in people with Firearm Injury, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Houston-HVIP). Read more about this study

Who is it for?
Ages 16 to 40 years
Conditions the study is for
Firearm Injury
What is being tested?
Houston-HVIP treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
274 participants
Where
1 siteUnited States
Study dates
16 Sep 2025to 31 May 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 40 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • presented for a gunshot injury stemming from community violence at Memorial Hermann Hospital
  • English or Spanish-speaking
  • provide informed voluntary consent to participate in the study
  • live in Harris County at time of enrollment
  • live within 40-mile radius of Memorial Hermann Hospital- Texas Medical Center

Who cannot join

  • presenting for a firearm injury arising from a self-inflicted gunshot or unintentional gun violence
  • actively detained by criminal justice systems at time of enrollment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030

    Sandra McKay, MD, 713-500-5666, Sandra.McKay@uth.tmc.edu

    Alexander Testa, PhD, (210) 276-9000, Alexander.Testa@uth.tmc.edu

    Recruiting

Other trials in United States

About this study

Official title: Launching the Houston-HVIP: Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence

A prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Houston-HVIP). Using a randomized controlled trial, the study will assess the effectiveness of Houston-HVIP in reducing violent reinjury and improving behavioral, mental, and physical health outcomes over a 12-month follow-up period among those enrolled in the study in ages 16-35 years of age.

Conditions
Firearm Injury
Being tested
Houston-HVIP treatment, Standard of Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Houston-HVIP treatmentBehavioural

    Participants will be assigned a case manager to provide a brief assessment of , psychological and social needs and a risk assessment and create individualized discharge planning. Participants will be referred to tailored social service programs based on the needs, including assessments of social determinants of health, educational and financial needs, and subsequent referral for programs such as job training, educational support, housing assistance, or financial assistance programs for identified needs. Participants identified at risk for violence perpetration via a risk assessment screener will be referred to the violence interrupter services. Long-term opportunities for engagement with the trauma survivors' network within Memorial Hermann Hospital will be available and encouraged.Participants will receive a structured curriculum that will include regular check-in with an assigned case manager over 6 months to promote successful community-based program integration and completion.

  • Standard of CareBehavioural

    Participants will be assigned a case manager to meet with the injured patients to briefly assess (a) psychological and social needs and (b) a risk assessment and create individualized discharge planning. Resources for the patient to connect with social service programs will be provided by the case manager. Long-term opportunities for engagement with the trauma survivors' network within Memorial Hermann Hospital will be available and encouraged. Follow-up contacts and services from an assigned case manager over two weeks following discharge from the hospital to ensure that the patient has contacted the community-level violence outreach organizations.

Study groups in NCT06263647
Study groupRoleWhat they receive
Houston-HVIP treatment groupExperimentalNot described
Receives: Behavioral: Houston-HVIP treatment
Standard of Care groupActive comparatorNot described
Receives: Behavioral: Standard of Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in repeat violent victimization as assessed by the number of participants who return to the hospital system for for an intentional firearm injury

    Measured: Baseline , 3 months, 6 months, 9 months and 12 months

Secondary outcomes (5)
  1. Change in repeat non-firearm violent victimization as assessed by the number of participants who return to the hospital system for an intentional non-firearm injury

    Measured: Baseline , 3 months, 6 months, 9 months and 12 months

  2. Change in attitudes towards firearm violence as assessed by Firearm Violences Attitudes (Sheley; Shapiro) questionnaire

    This is a 13-item questionnaire; however, only items 3,4,7,9,10,12 and 13 will be asked. Each is scored from 1(strongly disagree) - 4(strongly agree), Maximum score of 28 .Higher score indicates more aggression.

    Measured: Baseline , 3 months, 6 months, 9 months and 12 months

  3. Change in post-traumatic stress as assessed by the post-Traumatic Stress Disorder Checklist Version 5(PCL-5)

    This is a 20-item questionnaire; however only items 1 and 4 of the PCL-20 will be asked. These 2 items will be anchored to a stressful experience. And each is scored form 0(not at all)-4(extremely), maximum score of 8, higher score indicating worse outcome

    Measured: Baseline , 3 months, 6 months, 9 months and 12 months

  4. Change in aggression as assessed by the Copeland-Linder questionnaire.

    This is a 7-item questionnaire; however, only items 1, 5, and 6 will be asked. Each is scored from 1(strongly disagree) - 4(strongly agree). Maximum score is 12. Higher score indicates more aggression

    Measured: Baseline , 3 months, 6 months, 9 months and 12 months

  5. Change in general health as assessed by the 12-item Short Form Health Survey (SF-12)

    This is a 12 item questionnaire; however, only item #1 will be asked. It is scored from 1(excellent) - 5(poor), higher number indicating worse outcome

    Measured: Baseline , 3 months, 6 months, 9 months and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2024
  2. Study start16 Sep 2025
  3. Primary completion1 Feb 2028 (estimated)
  4. Study completion31 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
274 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06263647
Sponsor's protocol ID
HSC-MS-23-0904
Other IDs
UG3NR021232, UH3NR021232
Status last verified
Oct 2026
First submitted
8 Feb 2024
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Houston-HVIP treatment in people with Firearm Injury, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sandra McKay, MD ((713) 500-5666, Sandra.McKay@uth.tmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in repeat violent victimization as assessed by the number of participants who return to the hospital system for for an intentional firearm injury (time frame: Baseline , 3 months, 6 months, 9 months and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in